HomeEXECUTIVESBud Flagstad Appointed CEO of Care Angel

Bud Flagstad Appointed CEO of Care Angel

Bud Flagstad is a respected leader in the healthcare technology space where he most recently held the position of senior vice president of UnitedHealth Group Research & Development.

In this role, Bud Flagstad was responsible for driving consumer and provider engagement to reduce healthcare costs, increase access to high-quality care, enhance system efficiency and efficacy, and empower consumers to maintain or improve their health and wellbeing.

“After working with Bud as an investor and advisor to Care Angel for over a year, we are excited to welcome him to the Care Angel family as CEO,” said Wolf Shlagman, Care Angel founder and former CEO.  “The timing couldn’t be better to have him lead our revenue acceleration ramp and make sure we have the right partners to help fund our exponential growth. Bud has a proven track record and experience with some of the largest players in the market using transformative healthcare products that have impacted tens of millions of lives. I look forward to scaling the organization in collaboration with him.”

As the Care Angel model evolves, Mr. Shlagman will continue to play the vital role of developing the product vision as the chief product and innovation officer. “Wolf is well known for his heavy innovation experience, and his early contributions to building the framework of what the telemedicine industry is today,” said Care Angel chairman of the board, Patrick Byrne. Mr. Shlagman is a lifelong entrepreneur with 20+ years’ experience designing products and leading teams, is the founder of Consult A Doctor, which was acquired by Teladoc Health in 2013. “In his new role, Wolf will continue to leverage his deep technology knowledge as we deliver on the vision to deploy care at scale to the most at-risk populations globally.”

Over his prominent 30+ year career, Bud Flagstad has held executive leadership roles across the health insurance, private equity, medical startup and financial services industries. During his time at UnitedHealth Group specifically, a prestigious Fortune 50 company, he also spearheaded numerous projects, strategic partnerships and acquisitions.  Mr. Flagstad earned his Bachelor of Science in computer science and business administration at Minnesota State University.

“Working with Care Angel for over a year as both an investor and an advisor made it very apparent to me the potential impact the company can have on helping to build a better healthcare system with their solutions, supporting improved outcomes, reducing costs and expanding accessibility,” said Mr. Flagstad. “I truly look forward to joining such an incredible team.”

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.


"We are excited to welcome Jeff Anderson to Nutjobs as our new CEO. His broad experience and tactical leadership will be instrumental in executing against our vision to provide innovative, sustainable solutions to our customers," said Paul Kephart, Co-Founder, Chief Technology Officer and Chairperson of the Nutjobs Board.
Potrero Medical believes that this voluntary reorganization will bolster its finances and facilitate its ongoing focus on elevating patient care.
Dr John Parker will work closely with PeriGen's client base to optimize use of the company's analytics for patient care and research. He will also be instrumental in informing product development and regulatory affairs as PeriGen continues to expand its product suite and associated services.
“We’re delighted to welcome Gerald and Hannah to the PrecisionLife team at a time when our deep disease insights and patient stratification biomarkers are finding important new markets and bringing precision approaches to the early, more accurate diagnosis and care of patients with complex chronic diseases,” said Dr Steve Gardner, PrecisionLife CEO.
Broken String Biosciences reports Gavin Burns will be responsible for building and optimizing the companys teams, processes, and systems.

By using this website you agree to accept Medical Device News Magazine Privacy Policy